Global Lipid Regulators Market Overview And Statistics For 2024-2033

August 02, 2024 09:36 PM AEST | By EIN Presswire
 Global Lipid Regulators Market Overview And Statistics For 2024-2033
Image source: EIN Presswire

LONDON, GREATER LONDON, UK, August 2, 2024 /EINPresswire.com/ -- The lipid regulators market has experienced robust growth in recent years, expanding from $6.83 billion in 2023 to $7.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increased prevalence of lifestyle diseases, growth in aging population, increased awareness of lipid regulators, increased healthcare expenditure, increased focus on healthcare prevention.

Strong Future Growth Anticipated
The lipid regulators market is projected to continue its strong growth, reaching $9.55 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, rising incidence of atherosclerosis with aging, increasing obesity rates, the rising prevalence of metabolic syndrome, growing focus on personalized medicine.

Explore Comprehensive Insights Into The Global Lipid Regulators Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=15848&type=smp

Growth Driver Of The Lipid Regulators Market
The increasing prevalence of ischemic heart disease is expected to propel the growth of the lipid regulator market going forward. Ischemic heart disease (IHD), commonly known as coronary artery disease (CAD), is a disorder in which the coronary arteries restrict or become blocked, resulting in reduced blood flow to the heart muscle. Ischemic heart disease (IHD) is increasing due to factors such as unhealthy diets, smoking, obesity, hypertension, and diabetes. Lipid regulators help in ischemic heart disease by lowering LDL cholesterol, raising HDL cholesterol, stabilizing arterial plaques, reducing inflammation, and improving endothelial function, thereby reducing the risk and severity of ischemic events.

Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/lipid-regulators-global-market-report

Major Players And Market Trends
Key players in the lipid regulators market include Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca plc, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG.
Major companies operating in the lipid regulator market are developing advanced oral lipid-lowering drugs to help manage high low-density lipoprotein (LDL) cholesterol in patients with heart diseases. Oral lipid-lowering medications are intended for those who have an inherited genetic abnormality that causes high cholesterol or who have developed heart disease.

Segments:
1) By Type: Lipid Regulators, Narcotic Analgesics, Angiotensin Converting Enzyme (ACE) Inhibitors, Respiratory Agents, Diuretics, Calcium Antagonists, Hormonal Contraceptives, Other Types
2) By Indication: Hypercholesterolemia, Hypertriglyceridemia, Coronary Artery Disease, Other Indications
3) By Administration: Oral, Injectable
4) By Application: Pharmaceuticals, Vaccines And Drugs, Scientific Research, Nutrition And Supplements, Food And Beverages, Other Applications

Geographical Insights: North America Leading The Market
North America was the largest region in the lipid regulators market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lipid regulators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Lipid Regulators Market Definition
Lipid regulators, also known as lipid-lowering drugs or hypolipidemic agents, are medications used to control blood lipid levels, specifically cholesterol and triglycerides. The main role of lipid regulators is to minimize the risk of cardiovascular disease, while they also contain anti-inflammatory properties that can help stabilize existing plaques and reduce the possibility of plaque rupture and related cardiovascular events.

Lipid Regulators Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Lipid Regulators Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on lipid regulators market size, lipid regulators market drivers and trends, lipid regulators market major players, lipid regulators competitors' revenues, lipid regulators market positioning, and lipid regulators market growth across geographies. The lipid regulators market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Antiphospholipid Syndrome Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiphospholipid-syndrome-treatment-global-market-report

Lipid Nanoparticles Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lipid-nanoparticles-global-market-report

Lipid Disorder Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/lipid-disorder-treatment-global-market-report

About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.